Albert David — 360° view

Albert David, a company in the Pharmaceuticals industry, reported revenue of ₹101 crore and net profit of ₹2.88 crore for the September 2026 quarter.

Albert David (NSE: ALBERTDAVD) closed at ₹762.60 on 20 Nov 2026, down 4.8% over the past year. Its market capitalisation is ₹435 crore and it trades at 15.2 times earnings.

Share price
₹762.60 (20 Nov 2026)
Market cap
₹435 Cr (20 Nov 2026)
P/E
15.15 (20 Nov 2026)
Revenue
₹101 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
0.82% (FY26)
ROE
-0.44% (FY26)
Book value
₹739 (FY26)
Dividend yield
0.66% (last 12 months to 20 Nov 2026)
52-week high / low
₹931.85 / ₹579.90 (20 Nov 2026)
1-year return
-4.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ALBERTDAVD

Incorporated in 1938, Albert David Ltd is in the business of manufacturing pharmaceutical products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.